Trial intelligence / Profile preview

Midodrine vs Abdominal Compression in Autonomic Failure

NCT04620382Phase 1Completed

Sponsor
Vanderbilt University Medical Center
Start
Nov 2020
Primary completion
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of midodrine in Neurogenic Orthostatic Hypotension (nOH) (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Augmentation Index at 1 hour. Started Nov 2020; status: completed.

02

Drugs

midodrine
03

Conditions

Neurogenic Orthostatic Hypotension (nOH)

Beyond the preview

Go deeper on NCT04620382.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04620382.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call